News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
149 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (25773)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (243)
2 (71)
4 (13)
5 (208)
6 (219)
7 (196)
8 (217)
9 (66)
11 (10)
12 (147)
13 (179)
14 (161)
15 (149)
16 (59)
18 (5)
19 (123)
20 (157)
21 (145)
22 (146)
23 (65)
24 (1)
25 (5)
26 (148)
27 (167)
28 (180)
29 (149)
30 (99)
31 (2)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
11
12
13
14
15
16
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Deals
Salveo Diagnostics Merges Two Local Companies into its Growing Portfolio
Addition of ImmunArray autoimmune testing assets, Nudge patient-engagement capabilities enhances diagnostic and patient support offerings
August 15, 2019
·
3 min read
Business
A Family Affair: Kaspar Brothers Replaced at AveXis Amid Data Manipulation Scandal
In a brief announcement, AveXis said the Kaspar brothers have not been involved in any operations at AveXis since early May, seemingly ahead of the U.S. Food and Drug Administration’s approval of Zolgensma.
August 15, 2019
·
2 min read
·
Alex Keown
Business
After AbbVie Acquisition, Allergan’s Saunders Can Walk Away with $39 Million
According to a regulatory filing, Saunders will walk away with $14.9 million in cash and $23.6 million in equity, mostly stock based on performance.
August 15, 2019
·
3 min read
·
Mark Terry
Genetown
IDTechEx Forecasts Advanced Wound Care Market to Exceed $22 Billion by 2030
IDTechEx, a market intelligence company focusing on emerging technologies, has released a new report titled “Advanced Wound Care Technologies 2020–2030”.
August 15, 2019
·
2 min read
Business
Evotec Se Reports First Half-Year 2019 Results And Corporate Updates
Evotec SE reported financial results and corporate updates for the first half of 2019.
August 15, 2019
·
15 min read
Job Trends
Saranas Recognized as One of Houston’s Most Innovative Companies
Saranas Inc. announced that it has been named one of Houston’s most innovative companies.
August 15, 2019
·
1 min read
Arizona State University Researchers Try Novel Approach to Alzheimer’s Prevention
Researchers at Arizona State University are experimenting with a compound that might prevent Alzheimer’s and other neurodegenerative diseases, such as Parkinson’s disease, and potentially Down syndrome.
August 15, 2019
·
2 min read
·
Mark Terry
Business
Cal State LA honors renowned microbiologist, emerging bioscience entrepreneurs
Jill Adler-Moore, a renowned microbiologist and professor emerita at Cal Poly Pomona, was honored for her research, leadership and years of mentorship during a Cal State LA BioSpace event celebrating emerging entrepreneurs.
August 15, 2019
·
4 min read
Drug Development
After Suspending Generics Spin-Off, Mallinckrodt Eyes Potential FDA Approval of Liver Disease Drug
Mallinckrodt’s experimental drug terlipressin hit the mark in a late-stage liver disease trial. Mallinckrodt said terlipressin met its primary endpoint in reversing three components of hepatorenal syndrome type 1.
August 15, 2019
·
2 min read
·
Alex Keown
Biotech Bay
Research Roundup: Radical Insights into Cellular Dark Matter and More
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
August 15, 2019
·
5 min read
·
Mark Terry
1 of 15
Next